Registering Patients on Peritoneal Dialysis in China
Peritoneal Dialysis Registration System (PERSIST)
Recruiting
Observational Study
ESRD
Disorders Associated With Peritoneal Dialysis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- Sun Yat-sen University · Other
Who this trial is looking for
This trial is looking for patients who are currently receiving peritoneal dialysis. Participants will be monitored every three months to collect important health information related to their treatment and quality of life.
Are You a Good Fit for This Trial?
You may be able to join if
- I am currently receiving peritoneal dialysis
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Brief Summary: The investigators are registering all PD patients at recruited hospitals and developing a PD database in China. Patients will be followed up every 3 months, and both baseline and follow-up information will be collected and input into the registration system. The patient survival, technical survival, peritonitis rate, longitudinal changes of residual renal function and peritoneum fun…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:PD patients -
Exclusion Criteria:No
\-
Contacts